Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q4 2025 value amounting to 0.37%.

  • Agios Pharmaceuticals' Return on Capital Employed fell 1200.0% to 0.37% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.37%, marking a year-over-year decrease of 1200.0%. This contributed to the annual value of 0.34% for FY2025, which is 100.0% up from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Return on Capital Employed of 0.37% as of Q4 2025, which was down 1200.0% from 0.35% recorded in Q3 2025.
  • Over the past 5 years, Agios Pharmaceuticals' Return on Capital Employed peaked at 0.17% during Q2 2021, and registered a low of 0.54% during Q2 2024.
  • Over the past 5 years, Agios Pharmaceuticals' median Return on Capital Employed value was 0.33% (recorded in 2022), while the average stood at 0.33%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first skyrocketed by 2500bps in 2021, then plummeted by -1900bps in 2024.
  • Over the past 5 years, Agios Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.26% in 2021, then fell by -28bps to 0.34% in 2022, then decreased by -28bps to 0.43% in 2023, then skyrocketed by 40bps to 0.26% in 2024, then plummeted by -45bps to 0.37% in 2025.
  • Its Return on Capital Employed stands at 0.37% for Q4 2025, versus 0.35% for Q3 2025 and 0.32% for Q2 2025.